Latest Breaking News On - Ronen bezalel - Page 1 : comparemela.com

Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement Merger brings lead compound CM-101, a first in class anti-CCL24 antibody into advanced clinical development for fibrosis-related diseases with significant unmet medical need Concurrent PIPE financing to be used to fund clinical trials for CM-101 in fibrotic indications, focusing on two rare diseases and backed by leading healthcare-focused investors OrbiMed and Peter Thiel CAMBRIDGE, Mass. and TEL-AVIV, Israel, Dec. 15, 2020 Anchiano Therapeutics Ltd. (“Anchiano”) (Nasdaq: ANCN), a preclinical biopharmaceutical company, and Chemomab Ltd. (“Chemomab”), a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, announce their entry into a definitive merger agreement pursuant to which the shareholders of Chemomab wou

Israel
Cambridge
Cambridgeshire
United-kingdom
Anchiano-adss
Ronen-bezalel
Stan-polovets
Neil-cohen
Peter-thiel
Shachar-hadar
Goldfarb-seligman
Stephen-squinto